Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Feb 11  •  04:00PM ET
22.80
Dollar change
+0.23
Percentage change
1.02
%
IndexRUT P/E- EPS (ttm)-24.21 Insider Own2.06% Shs Outstand57.19M Perf Week-0.04%
Market Cap1.30B Forward P/E6.67 EPS next Y3.42 Insider Trans1.99% Shs Float56.01M Perf Month-15.40%
Enterprise Value2.71B PEG0.63 EPS next Q0.84 Inst Own113.95% Short Float15.56% Perf Quarter-24.65%
Income-1.37B P/S0.58 EPS this Y12.62% Inst Trans-4.85% Short Ratio9.15 Perf Half Y-20.70%
Sales2.23B P/B0.65 EPS next Y6.81% ROA-27.39% Short Interest8.72M Perf YTD-14.41%
Book/sh35.33 P/C38.78 EPS next 5Y10.52% ROE-51.11% 52W High44.76 -49.06% Perf Year-48.13%
Cash/sh0.59 P/FCF57.26 EPS past 3/5Y- -4.65% ROIC-40.00% 52W Low21.00 8.57% Perf 3Y-63.44%
Dividend Est.- EV/EBITDA9.65 Sales past 3/5Y13.90% -8.73% Gross Margin51.54% Volatility5.37% 5.19% Perf 5Y-66.78%
Dividend TTM- EV/Sales1.22 EPS Y/Y TTM-1016.39% Oper. Margin-0.48% ATR (14)1.22 Perf 10Y-44.81%
Dividend Ex-Date- Quick Ratio1.16 Sales Y/Y TTM11.57% Profit Margin-61.22% RSI (14)44.13 Recom1.25
Dividend Gr. 3/5Y- - Current Ratio2.22 EPS Q/Q-1664.17% SMA200.08% Beta1.26 Target Price45.09
Payout- Debt/Eq0.71 Sales Q/Q8.65% SMA50-10.71% Rel Volume1.13 Prev Close22.57
Employees7367 LT Debt/Eq0.69 EarningsFeb 26 BMO SMA200-23.48% Avg Volume953.01K Price22.80
IPOMay 08, 2008 Option/ShortYes / Yes EPS/Sales Surpr.15.56% 1.91% Trades Volume1,074,331 Change1.02%
Date Action Analyst Rating Change Price Target Change
Jan-06-26Initiated BTIG Research Buy $41
Oct-03-24Initiated JMP Securities Mkt Outperform $62
Jun-13-24Initiated JP Morgan Neutral $53
Feb-13-24Initiated Stephens Overweight $72
Jan-22-24Initiated UBS Buy $75
Jan-03-24Initiated William Blair Outperform
Dec-15-23Reiterated Needham Buy $62 → $70
Oct-20-23Initiated ROTH MKM Buy $75
Jun-26-23Initiated Needham Buy $70
May-12-23Upgrade Wells Fargo Equal Weight → Overweight $55 → $67
Feb-10-26 02:56PM
Feb-03-26 08:00AM
Jan-23-26 08:30AM
Jan-22-26 10:21PM
Jan-20-26 10:23AM
07:30AM Loading…
Jan-08-26 07:30AM
Jan-05-26 04:15PM
Dec-17-25 01:01PM
Nov-21-25 06:35PM
Nov-13-25 11:01PM
12:35AM
Nov-12-25 10:35PM
Nov-09-25 11:45PM
Nov-07-25 09:55AM
Nov-06-25 08:53AM
07:15AM Loading…
07:15AM
06:14AM
06:01AM
Nov-04-25 10:18PM
Oct-24-25 04:11PM
Oct-14-25 01:06PM
Oct-08-25 01:45PM
08:15AM
Sep-08-25 04:05PM
Sep-03-25 09:55AM
Aug-27-25 12:00AM
Aug-26-25 11:35PM
Aug-18-25 09:55AM
Aug-14-25 01:34AM
Aug-13-25 12:08PM
03:24AM Loading…
Aug-12-25 03:24AM
Aug-08-25 09:00AM
Aug-07-25 02:06PM
07:20AM
06:15AM
06:00AM
Aug-05-25 11:04PM
Jul-28-25 12:04AM
Jul-21-25 01:16PM
Jul-18-25 03:10PM
Jul-16-25 09:39AM
Jul-08-25 04:05PM
Jun-27-25 05:38AM
Jun-24-25 05:42PM
Jun-06-25 04:05PM
May-15-25 11:31PM
May-09-25 03:16AM
May-08-25 07:30AM
06:29AM
06:00AM
May-07-25 06:00PM
11:15AM
May-02-25 12:34AM
Apr-29-25 09:02AM
Apr-22-25 09:06AM
Apr-18-25 05:16AM
Apr-17-25 07:00AM
Apr-07-25 04:33AM
Apr-02-25 06:30AM
Mar-31-25 09:02AM
Mar-27-25 10:35PM
Mar-25-25 08:00AM
Mar-18-25 09:02AM
Mar-05-25 04:05PM
Feb-27-25 02:09AM
01:11AM
Feb-26-25 07:15AM
06:43AM
06:21AM
06:01AM
06:00AM
Feb-25-25 08:11AM
Jan-29-25 07:00AM
Jan-17-25 06:00AM
Jan-08-25 10:36AM
Jan-07-25 06:19PM
06:19PM
Jan-06-25 04:15PM
Nov-18-24 04:10PM
Nov-08-24 12:00PM
09:55AM
Nov-07-24 02:10AM
12:58AM
Nov-06-24 07:15AM
06:17AM
06:00AM
Oct-31-24 12:02PM
04:32AM
Oct-10-24 07:00AM
Oct-03-24 03:39PM
Sep-09-24 03:50PM
Sep-05-24 08:00AM
05:29AM
Aug-20-24 11:54AM
08:00AM
05:52AM
Aug-19-24 08:00AM
Aug-12-24 04:10PM
04:12AM
Aug-08-24 05:11AM
Enovis Corp. operates as a medical technology growth company. It develops clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. The firm operates through the following segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative disease. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. The company was founded by Mitchell P. Rales and Steven M. Rales in 1995 and is headquartered in Wilmington, DE.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PRYOR DANIEL AFormer EVP, Strategy & Bus DevDec 09 '25Sale27.2099927,1760Dec 11 09:00 PM
PRYOR DANIEL AFormer EVP, Strategy & Bus DevDec 09 '25Sale27.2166618,122160,449Dec 11 09:00 PM
KLECKNER JOHNPrincipal Accounting OfficerNov 25 '25Buy30.322,46874,83012,302Nov 28 04:30 PM
McDonald DamienChief Executive OfficerSep 11 '25Buy30.976,457199,973102,753Sep 11 05:59 PM
Tandy Bradley JSVP and Chief Legal OfficerAug 22 '25Buy31.413,200100,51243,515Aug 25 06:30 AM
BERRY PHILLIP BENJAMIN (BEN)SVP, Chief Financial OfficerAug 20 '25Buy29.712,50074,275116,729Aug 20 05:00 PM
PRYOR DANIEL AEVP, Strategy & Business Dev.Aug 13 '25Buy28.9010,000289,000161,115Aug 14 04:05 PM
Last Close
Feb 11  •  04:00PM ET
140.01
Dollar change
-0.16
Percentage change
-0.11
%
ATR Aptargroup Inc daily Stock Chart
Index- P/E23.80 EPS (ttm)5.88 Insider Own0.99% Shs Outstand64.20M Perf Week8.34%
Market Cap9.01B Forward P/E21.57 EPS next Y6.49 Insider Trans-3.14% Shs Float63.74M Perf Month11.89%
Enterprise Value10.20B PEG2.71 EPS next Q1.15 Inst Own93.48% Short Float1.92% Perf Quarter20.30%
Income392.79M P/S2.39 EPS this Y-2.61% Inst Trans-0.27% Short Ratio2.24 Perf Half Y0.38%
Sales3.78B P/B3.37 EPS next Y16.13% ROA8.11% Short Interest1.23M Perf YTD14.80%
Book/sh41.56 P/C21.98 EPS next 5Y7.97% ROE15.28% 52W High164.28 -14.77% Perf Year-1.60%
Cash/sh6.37 P/FCF30.09 EPS past 3/5Y17.89% 12.87% ROIC10.19% 52W Low103.23 35.63% Perf 3Y28.20%
Dividend Est.1.96 (1.40%) EV/EBITDA12.77 Sales past 3/5Y4.37% 5.22% Gross Margin29.58% Volatility4.18% 2.60% Perf 5Y-2.07%
Dividend TTM1.86 (1.33%) EV/Sales2.70 EPS Y/Y TTM5.80% Oper. Margin13.53% ATR (14)3.74 Perf 10Y88.39%
Dividend Ex-DateFeb 04, 2026 Quick Ratio1.16 Sales Y/Y TTM5.42% Profit Margin10.40% RSI (14)72.18 Recom1.90
Dividend Gr. 3/5Y6.38% 4.91% Current Ratio1.62 EPS Q/Q-23.97% SMA209.59% Beta0.47 Target Price161.00
Payout31.11% Debt/Eq0.58 Sales Q/Q13.52% SMA5012.70% Rel Volume1.07 Prev Close140.17
Employees14000 LT Debt/Eq0.45 EarningsFeb 05 AMC SMA2001.97% Avg Volume548.08K Price140.01
IPOApr 23, 1993 Option/ShortYes / Yes EPS/Sales Surpr.1.74% 9.58% Trades Volume584,269 Change-0.11%
Date Action Analyst Rating Change Price Target Change
Jan-06-26Downgrade Wells Fargo Overweight → Equal Weight $133
Nov-03-25Downgrade William Blair Outperform → Mkt Perform
Sep-04-25Initiated KeyBanc Capital Markets Overweight $220
Jan-07-25Initiated Raymond James Outperform $200
Jan-06-25Downgrade BofA Securities Buy → Neutral $173
Oct-14-24Upgrade Jefferies Hold → Buy $155 → $215
Apr-29-24Upgrade William Blair Mkt Perform → Outperform
Jan-03-24Upgrade Robert W. Baird Neutral → Outperform $125 → $150
Aug-02-21Downgrade William Blair Outperform → Mkt Perform
Apr-14-21Downgrade Robert W. Baird Outperform → Neutral $150
Feb-10-26 09:15AM
Feb-09-26 01:20PM
Feb-08-26 11:40PM
Feb-06-26 05:33PM
04:01PM
07:00PM Loading…
Feb-05-26 07:00PM
06:10PM
05:23PM
05:00PM
Feb-03-26 07:40AM
Jan-29-26 10:00AM
Jan-28-26 12:29PM
Jan-22-26 05:00PM
Jan-15-26 09:24AM
Jan-07-26 05:00PM
09:55AM Loading…
09:55AM
Jan-06-26 05:00PM
Jan-05-26 05:00PM
Dec-17-25 05:00PM
Dec-09-25 08:28AM
04:00AM
Dec-04-25 05:00PM
Dec-03-25 11:01AM
Nov-11-25 05:00PM
Nov-04-25 01:56AM
Oct-31-25 03:04PM
03:33AM
Oct-30-25 07:00PM
06:15PM
05:11PM
05:00PM Loading…
05:00PM
10:21AM
09:24AM
Oct-29-25 01:59PM
Oct-28-25 02:21PM
12:50PM
11:27AM
10:00AM
04:48AM
Oct-27-25 11:57AM
11:50AM
11:11AM
Oct-23-25 11:07AM
10:00AM
08:59AM
Oct-22-25 12:43PM
07:55AM
Oct-21-25 12:10PM
Oct-16-25 08:00AM
Oct-13-25 08:47AM
Sep-18-25 10:44AM
Sep-09-25 12:28PM
Sep-08-25 05:00PM
Sep-04-25 05:00PM
Aug-09-25 11:59PM
Aug-05-25 12:58PM
12:56PM
Aug-04-25 06:24PM
Aug-02-25 03:09AM
Aug-01-25 09:45AM
Jul-31-25 06:15PM
05:14PM
05:00PM
10:04AM
09:21AM
Jul-30-25 11:39AM
10:52AM
09:25AM
Jul-29-25 10:00AM
Jul-25-25 10:49AM
Jul-24-25 01:22PM
10:00AM
Jul-22-25 12:10PM
11:38AM
10:10AM
Jul-10-25 05:00PM
Jul-08-25 05:00PM
Jul-07-25 08:12AM
Jun-27-25 09:39AM
Jun-25-25 05:00PM
Jun-24-25 09:37AM
Jun-23-25 03:00PM
Jun-20-25 12:00PM
10:04AM
Jun-18-25 08:08AM
Jun-16-25 11:24AM
11:04AM
Jun-12-25 10:14AM
Jun-10-25 09:35AM
09:25AM
Jun-04-25 10:59AM
Jun-02-25 05:00PM
May-29-25 05:00PM
10:46AM
10:04AM
May-27-25 10:30AM
10:26AM
09:45AM
May-23-25 10:32AM
06:52AM
AptarGroup, Inc. engages in the design, manufacture, drug delivery, consumer product dispensing, sealing and active packaging solutions, and services for the prescription drug, consumer health care, injectable, active packaging, beauty, personal care, home care, and food and beverages industries. It operates through the following segments: Pharma, Beauty and Home, and Food and Beverage. The company was founded in 1940 and is headquartered in Crystal Lake, IL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Prieur MarcSegment PresidentFeb 10 '26Sale137.812,000275,62013,745Feb 11 01:26 PM
Prieur MarcOfficerFeb 09 '26Proposed Sale136.002,000272,000Feb 09 12:59 PM
Ackerman DanielChief Accounting OfficerDec 12 '25Option Exercise71.1215,0001,066,80044,607Dec 15 06:22 PM
Ackerman DanielChief Accounting OfficerDec 12 '25Sale121.2315,0001,818,43529,607Dec 15 06:22 PM
DANIEL ACKERMANOfficerDec 12 '25Proposed Sale121.2315,0001,818,435Dec 12 04:25 PM
Touya GaelSegment PresidentSep 11 '25Sale136.122,500340,29831,463Sep 12 08:12 AM
GAEL TOUYAOfficerSep 11 '25Proposed Sale136.122,500340,298Sep 11 04:28 PM
Vinczeller ShielaChief Human Resources OfficerSep 05 '25Sale137.971,167161,00625,134Sep 08 12:50 PM
SHIELA PALLERNE VINCZELLEROfficerSep 05 '25Proposed Sale137.971,167161,006Sep 05 04:15 PM
Prieur MarcSegment PresidentJun 13 '25Sale152.802,000305,60615,745Jun 16 10:52 AM
Prieur MarcOfficerJun 13 '25Proposed Sale154.002,000308,000Jun 12 05:09 PM
Chainey KimberlyEVP and Chief Legal OfficerJun 10 '25Sale152.791,671255,31811,088Jun 10 05:57 PM
KIMBERLY CHAINEYOfficerJun 10 '25Proposed Sale152.791,671255,318Jun 10 04:21 PM
Touya GaelSegment PresidentJun 06 '25Sale152.623,300503,65433,963Jun 09 12:40 PM
GAEL TOUYAOfficerJun 06 '25Proposed Sale152.623,300503,654Jun 06 04:17 PM
Gong XiangweiPresident, AsiaMay 22 '25Sale156.497,0001,095,44610,265May 23 10:33 AM
XIANGWEI GONGOfficerMay 22 '25Proposed Sale156.497,0001,095,446May 22 04:11 PM
Prieur MarcSegment PresidentMay 20 '25Sale158.346,000950,04517,745May 21 11:50 AM
Prieur MarcOfficerMay 20 '25Proposed Sale158.006,000948,000May 20 06:47 AM
Tlili HediSegment PresidentMay 16 '25Sale155.963,614563,6429,379May 19 10:11 AM
HEDI TLILIOfficerMay 16 '25Proposed Sale155.963,614563,642May 16 04:39 PM
Vinczeller ShielaChief Human Resources OfficerMay 07 '25Sale152.42995151,65826,301May 08 05:35 PM
SHIELA PALLERNE VINCZELLEROfficerMay 07 '25Proposed Sale152.42995151,658May 07 04:21 PM
STEPHAN B TANDAOfficerMay 07 '25Proposed Sale151.2417,7712,687,714May 07 04:11 PM
Tanda Stephan B.President and CEOMay 07 '25Option Exercise74.7917,7711,329,093222,757May 07 04:06 PM
Tanda Stephan B.President and CEOMay 06 '25Option Exercise74.7990067,311205,886May 07 04:06 PM
Tanda Stephan B.President and CEOMay 07 '25Sale151.2417,7712,687,714204,986May 07 04:06 PM
Tanda Stephan B.President and CEOMay 06 '25Sale152.03900136,831204,986May 07 04:06 PM
STEPHAN B TANDAOfficerMay 06 '25Proposed Sale152.03900136,831May 06 04:20 PM
Tanda Stephan B.President and CEOMay 05 '25Option Exercise74.7911,329847,296216,315May 06 03:12 PM
Tanda Stephan B.President and CEOMay 05 '25Sale152.3911,3291,726,423204,986May 06 03:12 PM
STEPHAN B TANDAOfficerMay 05 '25Proposed Sale152.3911,3291,726,423May 05 04:15 PM